These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9828989)

  • 41. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study.
    Yang Q; Rasmussen SA; Friedman JM
    Lancet; 2002 Mar; 359(9311):1019-25. PubMed ID: 11937181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results of first year (1989) of a national register of Down's syndrome in England and Wales.
    Mutton DE; Alberman E; Ide R; Bobrow M
    BMJ; 1991 Nov; 303(6813):1295-7. PubMed ID: 1836152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alzheimer's disease in Down's syndrome: visual retention deficits.
    Dalton AJ; Crapper DR; Schlotterer GR
    Cortex; 1974 Dec; 10(4):366-77. PubMed ID: 4281378
    [No Abstract]   [Full Text] [Related]  

  • 44. Dementia in Down's syndrome.
    Ballard C; Mobley W; Hardy J; Williams G; Corbett A
    Lancet Neurol; 2016 May; 15(6):622-36. PubMed ID: 27302127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of Alzheimer's disease and other dementing disorders in Pamplona, Spain.
    Manubens JM; Martínez-Lage JM; Lacruz F; Muruzabal J; Larumbe R; Guarch C; Urrutia T; Sarrasqueta P; Martínez-Lage P; Rocca WA
    Neuroepidemiology; 1995; 14(4):155-64. PubMed ID: 7643949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Precocious aging and dementia in patients with Down's syndrome.
    Wisniewski K; Howe J; Williams DG; Wisniewski HM
    Biol Psychiatry; 1978 Oct; 13(5):619-27. PubMed ID: 153156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reliability of statistics on Down's syndrome notifications.
    Huang T; Watt HC; Wald NJ; Morris JK; Mutton D; Alberman E
    J Med Screen; 1997; 4(2):95-7. PubMed ID: 9275267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cognition in Down's Syndrome: Development across the Life Span and Neuropsychological Assessment in Adults].
    Loosli SV; Schmidt L; Nübling G; Wlasich E; Prix C; Danek A; Levin J
    Fortschr Neurol Psychiatr; 2021 Sep; 89(9):433-444. PubMed ID: 33647991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dementia in Down's syndrome: still much to learn.
    The Lancet Neurology
    Lancet Neurol; 2016 Jul; 15(8):775. PubMed ID: 27302342
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevalence and associated features of epilepsy in adults with Down's syndrome.
    McVicker RW; Shanks OE; McClelland RJ
    Br J Psychiatry; 1994 Apr; 164(4):528-32. PubMed ID: 8038944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alzheimer's disease in Down's syndrome.
    Owens D; Dawson JC; Losin S
    Am J Ment Defic; 1971 Mar; 75(5):606-12. PubMed ID: 4251658
    [No Abstract]   [Full Text] [Related]  

  • 52. Prevalence of visual impairment in adults with intellectual disabilities in the Netherlands: cross-sectional study.
    van Splunder J; Stilma JS; Bernsen RM; Evenhuis HM
    Eye (Lond); 2006 Sep; 20(9):1004-10. PubMed ID: 16151486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome.
    Morris JK; Mutton DE; Alberman E
    J Med Screen; 2002; 9(1):2-6. PubMed ID: 11943789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The prevalence and incidence of mental ill-health in adults with Down syndrome.
    Mantry D; Cooper SA; Smiley E; Morrison J; Allan L; Williamson A; Finlayson J; Jackson A
    J Intellect Disabil Res; 2008 Feb; 52(Pt 2):141-55. PubMed ID: 18197953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic criteria influence dementia prevalence.
    Wancata J; Börjesson-Hanson A; Ostling S; Sjögren K; Skoog I
    Am J Geriatr Psychiatry; 2007 Dec; 15(12):1034-45. PubMed ID: 18056822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behaviour phenotype for Down's syndrome.
    Collacott RA; Cooper SA; Branford D; McGrother C
    Br J Psychiatry; 1998 Jan; 172():85-9. PubMed ID: 9534839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of overweight and obesity in Down's syndrome and other mentally handicapped adults living in the community.
    Bell AJ; Bhate MS
    J Intellect Disabil Res; 1992 Aug; 36 ( Pt 4)():359-64. PubMed ID: 1388077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.
    Teipel SJ; Schapiro MB; Alexander GE; Krasuski JS; Horwitz B; Hoehne C; Möller HJ; Rapoport SI; Hampel H
    Am J Psychiatry; 2003 Oct; 160(10):1870-8. PubMed ID: 14514503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Different classification systems yield different dementia occurrence among nonagenarians and centenarians.
    Pioggiosi P; Forti P; Ravaglia G; Berardi D; Ferrari G; De Ronchi D
    Dement Geriatr Cogn Disord; 2004; 17(1-2):35-41. PubMed ID: 14560063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.